Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a conversation prevent HIV? study tests In-Person vs. online counseling for PrEP uptake

NCT ID NCT05804461

Prevention Sponsor: University of Puerto Rico Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests whether motivational interviewing — a counseling style that helps people find their own reasons to change — can increase the number of Latino men who have sex with men in Puerto Rico who start taking PrEP, a daily pill that prevents HIV. Researchers will compare delivering the counseling face-to-face versus online to see which works better. Participants are HIV-negative or unknown-status men aged 21 and older who are not currently using PrEP but meet CDC criteria for being at risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
motivational interviewing
What this could lead to
If successful, this could identify the most effective way to deliver counseling that helps Latino men at risk for HIV start taking PrEP, a daily pill that prevents infection.
What could go wrong
This is a behavioral study with 182 participants in one region, so results may not apply to other groups or settings. The intervention only aims to increase uptake, not to measure long-term adherence or HIV prevention directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 182 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2023

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 99 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Latino MSM group - Inclusion Criteria: * Biological male * Age 21 or older * Self-reported HIV negative or unknown status * Not using PrEP (participants who have discontinued PrEP use can participate in the study), Spanish fluency (ability to write and read in Spanish) * Presenting at least one of the eligibility criteria for PrEP as established by the CDC (including men who have had an infection (STI) in the past 6 months, HIV positive sexual partner) * Access to a portable technology device (e.g., phone, tablet, laptop) or desktop computer access to internet connection Exclusion Criteria: * HIV positive individual * Evidence of being under the effects of alcohol or drugs * Indication of unstable or serious psychiatric symptoms * Evidence of major cognitive impairment * Inability to speak and read in Spanish Healthcare Providers group - Inclusion Criteria: * Age 21 or older * Providing PrEP related health services at time of enrollment (e.g., case management, clinical services) * Spanish fluency (ability to write and read in Spanish) Exclusion Criteria: * Evidence of being under the effects of alcohol or drugs * Indication of unstable or serious psychiatric symptoms * Evidence of major cognitive impairment * Inability to speak and read in Spanish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV prevention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV prevention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Puerto Rico Medical Sciences Campus

    RECRUITING

    San Juan, 00936, Puerto Rico

More trials for these conditions

Other studies related to the condition(s) this trial covers.